eMedCodes logo

Treatment Set TS350622 - Treatment Set TS350622

Navigation: NDC > Supplier starting with: A > ANTIGEN LABORATORIES, INC.
Field Value
NDC Code: 49288-0942
Proprietary Name: Treatment Set TS350622
Suffix:
Non-Proprietary Name: Treatment Set TS350622
Dosage Form: INJECTION, SOLUTION
Method: INTRADERMAL; SUBCUTANEOUS
Original Marketing Date: 31-10-1986
Category Name: BLA
Application Number: BLA102223
Labeler: ANTIGEN LABORATORIES, INC.
Substance Name: ALTERNARIA ALTERNATA; AVENA SATIVA POLLEN; CANIS LUPUS FAMILIARIS HAIR; COCHLIOBOLUS SATIVUS; CYNODON DACTYLON POLLEN; FELIS CATUS HAIR; FESTUCA PRATENSIS POLLEN; PASCOPYRUM SMITHII POLLEN; PHLEUM PRATENSE POLLEN; SORGHUM HALEPENSE POLLEN
Active Numerator Strength: .002; .00008; .002; .002; 16; 400; 800; .002; 160; .0004
Active Ingredient Unit: g/mL; g/mL; g/mL; g/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; g/mL; [BAU]/mL; g/mL
Pharm Classes: Standardized Animal Hair Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Dander [Chemical/Ingredient],Allergens [Chemical/Ingredient],Salivary Proteins and Peptides [Chemical/Ingredient],Non-Standardized Animal Hair Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fur [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]
DEA Schedule: